Latest News - Biotech - United States - Maryland

- Five clones from ‘Booger’ were born by world’s first commercial order. - The project completed in only 70 days, boasting the efficacy of the technology. - RNL starts to offer cloning service, world-wide.

RNL Bio has signed a licensing agreement with a Japanese biotech company for RNL's stem cell technology to establish stem cell banks and to sell the stem cell therapeutics in Japan

RNL Bio now offers a stem cell bank facility for hepatitis virus carriers to store their own stem cells for future treatment.

Scientists made a significant advance in differentiation of adult stem cells into hepatobiliary cells.

Trevigen's Cultrex® 24 Well Cell Invasion Assay kits quantify the degree to which invasive cells penetrate either basement membrane extract, collagen I, collagen IV, or laminin I, in vitro.

When exposed to oxidative radicals, 8-hydroxy-2’-deoxyguanosine (8-oxo-dG) is formed and can serve as a sensitive indicator of physiological and environmental damage to DNA.

The dead pet dog's cells were arrived in Seoul Korea for the world's fisrt commercial dog cloning project.

Trevigen launches HT PARP/Apoptosis Assays ideal for measuring the activity of PARP in a high-throughput, 96-well format.

RNL Bio partners with Seoul National University's Veterinary Medical Teaching Hospital to offer stem cell therapeutics for pets and even pet cloning

Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. PathClear" BME is expected to be of special interest for research work requiring BME free from viruses, bacteria and mycoplasma.